SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001117480-21-000020
Filing Date
2021-08-05
Accepted
2021-08-05 07:51:00
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmrx-20210805.htm   iXBRL 8-K 42587
2 EX-99.1 exhibit99120210630cmrxearn.htm EX-99.1 103073
6 chimerixlogoa02.jpg GRAPHIC 13737
  Complete submission text file 0001117480-21-000020.txt   313331

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20210805.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20210805_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20210805_pre.xml EX-101.PRE 13046
7 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20210805_htm.xml XML 12057
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 211146378
SIC: 2834 Pharmaceutical Preparations